| ASSET | YEAR | % RETURN |
|---|---|---|
Volcon (VLCN) | 2024 | -99.88% |
RAPT Therapeutics (RAPT) | 2024 | -93.51% |
Barnes & Noble Education (BNED) | 2024 | -93.35% |
Helius Medical Technologies Inc Class A (HSDT) | 2024 | -91.31% |
Roboai (AIIO) | 2024 | -90.89% |
Editas Medicine (EDIT) | 2024 | -87.3% |
Ginkgo Bioworks (DNA) | 2024 | -85.21% |
Oncology Institute (TOI) | 2024 | -85.07% |
Upexi (UPXI) | 2024 | -85% |
agilon health (AGL) | 2024 | -84.71% |
Asset Entities Inc Class B Common Stock (ASST) | 2024 | -84.67% |
Wolfspeed (WOLF) | 2024 | -84.57% |
P3 Health Partners (PIII) | 2024 | -83.7% |
Pacific Biosciences of California (PACB) | 2024 | -81.11% |
Waldencast Acquisition (WALDW) | 2024 | -81.11% |
FuelCell Energy (FCEL) | 2024 | -80.93% |
908 Devices (MASS) | 2024 | -80.29% |
ZKH (ZKH) | 2024 | -78.33% |
Better Home & Finance (BETR) | 2024 | -77.42% |
Alector (ALEC) | 2024 | -76.05% |
Digital Turbine (APPS) | 2024 | -74.96% |
Sify Technologies (SIFY) | 2024 | -74.65% |
Amylyx Pharmaceuticals (AMLX) | 2024 | -74.32% |
Claritev (CTEV) | 2024 | -73.79% |
10X Genomics (TXG) | 2024 | -73.78% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
